Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 1
2008 1
2009 1
2010 1
2013 1
2014 1
2015 1
2016 2
2018 1
2019 1
2020 2
2021 7
2022 3
2023 2
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Results by year

Filters applied: . Clear all
Page 1
Single-cell analysis of MYD88L265P and MYD88WT Waldenström macroglobulinemia patients.
Bagratuni T, Aktypi F, Theologi O, Sakkou M, Verrou KM, Mavrianou-Koutsoukou N, Patseas D, Liacos C, Skourti S, Papadimou A, Taouxi K, Theodorakakou F, Kollias G, Sfikakis P, Terpos E, Dimopoulos MA, Kastritis E. Bagratuni T, et al. Among authors: liacos c. Hemasphere. 2024 Feb 8;8(2):e27. doi: 10.1002/hem3.27. eCollection 2024 Feb. Hemasphere. 2024. PMID: 38435423 Free PMC article.
Mutations in the alternative complement pathway in multiple myeloma patients with carfilzomib-induced thrombotic microangiopathy.
Moscvin M, Liacos CI, Chen T, Theodorakakou F, Fotiou D, Hossain S, Rowell S, Leblebjian H, Regan E, Czarnecki P, Bagnoli F, Bolli N, Richardson P, Rennke HG, Dimopoulos MA, Kastritis E, Bianchi G. Moscvin M, et al. Among authors: liacos ci. Blood Cancer J. 2023 Feb 27;13(1):31. doi: 10.1038/s41408-023-00802-0. Blood Cancer J. 2023. PMID: 36849497 Free PMC article.
Angiogenesis-related pathways in the pathogenesis of ovarian cancer.
Gavalas NG, Liontos M, Trachana SP, Bagratuni T, Arapinis C, Liacos C, Dimopoulos MA, Bamias A. Gavalas NG, et al. Among authors: liacos c. Int J Mol Sci. 2013 Jul 30;14(8):15885-909. doi: 10.3390/ijms140815885. Int J Mol Sci. 2013. PMID: 23903048 Free PMC article. Review.
Determination of MYD88L265P mutation fraction in IgM monoclonal gammopathies.
Bagratuni T, Markou A, Patseas D, Mavrianou-Koutsoukou N, Aktypi F, Liacos CI, Sklirou AD, Theodorakakou F, Ntanasis-Stathopoulos I, Gavriatopoulou M, Trougakos IP, Lianidou E, Terpos E, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: liacos ci. Blood Adv. 2022 Jan 11;6(1):189-199. doi: 10.1182/bloodadvances.2021005354. Blood Adv. 2022. PMID: 34788399 Free PMC article.
Small RNA-seq and clinical evaluation of tRNA-derived fragments in multiple myeloma: Loss of mitochondrial i-tRFHisGTG results in patients' poor treatment outcome.
Soureas K, Papadimitriou MA, Malandrakis P, Papanota AM, Adamopoulos PG, Ntanasis-Stathopoulos I, Liacos CI, Gavriatopoulou M, Sideris DC, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Avgeris M. Soureas K, et al. Among authors: liacos ci. Br J Haematol. 2024 May;204(5):1790-1800. doi: 10.1111/bjh.19332. Epub 2024 Feb 27. Br J Haematol. 2024. PMID: 38414235
Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study.
Cowan A, Ferrari F, Freeman SS, Redd R, El-Khoury H, Perry J, Patel V, Kaur P, Barr H, Lee DJ, Lightbody E, Downey K, Argyelan D, Theodorakakou F, Fotiou D, Liacos CI, Kanellias N, Chavda SJ, Ainley L, Sandecká V, Pospíšilová L, Minarik J, Jungova A, Radocha J, Spicka I, Nadeem O, Yong K, Hájek R, Kastritis E, Marinac CR, Dimopoulos MA, Get G, Trippa L, Ghobrial IM. Cowan A, et al. Among authors: liacos ci. Lancet Haematol. 2023 Mar;10(3):e203-e212. doi: 10.1016/S2352-3026(22)00386-6. Lancet Haematol. 2023. PMID: 36858677 Free PMC article.
A Cancer-Related microRNA Signature Shows Biomarker Utility in Multiple Myeloma.
Papanota AM, Karousi P, Kontos CK, Artemaki PI, Liacos CI, Papadimitriou MA, Bagratuni T, Eleutherakis-Papaiakovou E, Malandrakis P, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Scorilas A, Terpos E. Papanota AM, et al. Among authors: liacos ci. Int J Mol Sci. 2021 Dec 5;22(23):13144. doi: 10.3390/ijms222313144. Int J Mol Sci. 2021. PMID: 34884950 Free PMC article.
Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity.
Bagratuni T, Patseas D, Mavrianou-Koutsoukou N, Liacos CI, Sklirou AD, Rousakis P, Gavriatopoulou M, Terpos E, Tsitsilonis OE, Trougakos IP, Kastritis E, Dimopoulos MA. Bagratuni T, et al. Among authors: liacos ci. Cancers (Basel). 2020 Oct 5;12(10):2864. doi: 10.3390/cancers12102864. Cancers (Basel). 2020. PMID: 33028016 Free PMC article.
miRNA-seq and clinical evaluation in multiple myeloma: miR-181a overexpression predicts short-term disease progression and poor post-treatment outcome.
Papadimitriou MA, Papanota AM, Adamopoulos PG, Pilala KM, Liacos CI, Malandrakis P, Mavrianou-Koutsoukou N, Patseas D, Eleutherakis-Papaiakovou E, Gavriatopoulou M, Kastritis E, Avgeris M, Dimopoulos MA, Terpos E, Scorilas A. Papadimitriou MA, et al. Among authors: liacos ci. Br J Cancer. 2022 Jan;126(1):79-90. doi: 10.1038/s41416-021-01602-8. Epub 2021 Oct 30. Br J Cancer. 2022. PMID: 34718359 Free PMC article.
tRNA Derivatives in Multiple Myeloma: Investigation of the Potential Value of a tRNA-Derived Molecular Signature.
Karousi P, Papanota AM, Artemaki PI, Liacos CI, Patseas D, Mavrianou-Koutsoukou N, Liosi AA, Kalioraki MA, Ntanasis-Stathopoulos I, Gavriatopoulou M, Kastritis E, Dimopoulos MA, Scorilas A, Terpos E, Kontos CK. Karousi P, et al. Among authors: liacos ci. Biomedicines. 2021 Dec 1;9(12):1811. doi: 10.3390/biomedicines9121811. Biomedicines. 2021. PMID: 34944627 Free PMC article.
28 results